Telix Pharmaceuticals US Inc.
Fishers, IN
- UEI
- NMRHMBK4YTH7
- CAGE
- 8CP27
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
- Lake Mary, FL UA3GDUKRYSM5
-
- SAM.gov registration date
- Physical address
- 11700 Exit 5 Pkwy #200, Fishers, IN 46037, USA
- Website
- telixpharma.com
- Founded
- 2015
- Employees
- 251-1K
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $168,000 |
| FY2026 | $785,992 |
| FY2025 | $2,978,000 |
| FY2024 | $3,106,500 |
| FY2023 | $875,200 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Veterans Affairs | $953,992 |
Contract vehicles
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Illuccix | Veterans Integrated Service Network 17 (VHA) | $168,000 | |
| VA SAN diego psma | Veterans Integrated Service Network 22 (VHA) | $496,000 | |
| Illuccix | Veterans Integrated Service Network 22 (VHA) | $249,717 | |
| Illuccix | Veterans Integrated Service Network 8 (VHA) | $1,750,000 | |
| Various radiopharmaceuticals OPT YR 1 | Veterans Integrated Service Network 9 (VHA) | $857,500 |
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Sun Pharmaceutical Industries, Inc. | Princeton, NJ | 325412 Pharmaceutical Preparation Manufacturing |
| Lantheus Medical Imaging, Inc. | Bedford, MA | 325412 Pharmaceutical Preparation Manufacturing |
| Nuclear Diagnostic Products, Inc. | Rockaway, NJ | 325412 Pharmaceutical Preparation Manufacturing |
| Pharmalogic Puerto Rico | Boca Raton, FL | 325412 Pharmaceutical Preparation Manufacturing |
| Jubilant Draximage Radiopharmacies, Inc. | Orlando, FL | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Telix Pharmaceuticals US Inc., a Fishers, Indiana-based manufacturer of radiopharmaceutical products, operates as a prime contractor supplying specialized nuclear medicine and diagnostic imaging agents to the Department of Veterans Affairs across multiple Veterans Integrated Service Networks. The company competes full-and-open without set-aside designations.
Telix's federal footprint centers on radiopharmaceutical supply under the GSA Federal Supply Schedule 65-IB (Pharmaceuticals and Drugs). The company manufactures two primary product lines for VA procurement: Illuccix, a radiopharmaceutical for prostate cancer imaging (PSMA-targeted), and Gozetotide, used for broader nuclear medicine diagnostic procedures. Representative awards include a $4.557 million firm fixed-price delivery order from Veterans Integrated Service Network 22 running through December 31, 2030, for radiopharmaceutical products in support of VA nuclear medicine and oncology imaging; a $1.75 million BPA call from Veterans Integrated Service Network 8 through September 2026 for Illuccix supply; and a $1.141 million BPA call from the same network through September 2025. Work is performed primarily at Telix's facilities in Fishers, Indiana, with secondary performance locations in Dublin, Ohio and Norcross, Georgia.
Customer concentration is extreme: the Department of Veterans Affairs accounts for 100% of the measured award footprint, with 95% of awards concentrated among five VA customer entities. The VA National Acquisition Center anchors the dollar value at $17.5 million through a single-award BPA for Illuccix procurement running through August 26, 2026. VISN 22 and VISN 9 follow with $7.5 million and $7.3 million in combined potential value respectively across eight and five awards. VISN 8 holds $2.9 million across two awards, and VISN 12 holds $325 thousand across three awards. Telix maintains three active IDVs under Schedule 65-IB: the $17.5 million Illuccix BPA awarded August 30, 2022; a $4.394 million BPA for various radiopharmaceuticals with VISN 9 running through September 30, 2028; and a $225 thousand multiple-award Federal Supply Schedule contract awarded August 15, 2022, through August 14, 2027. The 21 recorded task orders against these vehicles carry $39.4 million combined potential value.
Recent activity declined from seven awards in 2022 to two awards year-to-date in 2026, though the $4.557 million July 2026 delivery order from VISN 22 represents a material four-year commitment. Only two awards (combined potential value $2.6 million) face ultimate completion within the next twenty-four months, suggesting minimal near-term recompete exposure. Telix obligated $8.3 million across its $35.6 million combined potential value, indicating active consumption of BPA and schedule capacity. The corporate structure includes a named subsidiary, RLS (USA) Inc., which the source does not characterize separately. The vendor operates exclusively as a prime contractor with no recorded subcontract engagement.
Quick answers
Is Telix Pharmaceuticals US Inc. registered in SAM.gov?
Yes. Telix Pharmaceuticals US Inc.'s SAM.gov registration is active through January 30, 2027.
Which contract vehicles does Telix Pharmaceuticals US Inc. hold?
Telix Pharmaceuticals US Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
How much has Telix Pharmaceuticals US Inc. received in federal contracts?
Federal contracts obligated $2,978,000 to Telix Pharmaceuticals US Inc. in fiscal year 2025 and $7,913,692 in fiscal years 2023 through 2027.
How does Telix Pharmaceuticals US Inc. rank among federal contractors?
Telix Pharmaceuticals US Inc. ranked #46 in NAICS 325412, #57 in PSC 6505 and #63 in NAICS 3254 in FY2025.
What is Telix Pharmaceuticals US Inc.'s most recent federal award?
Telix Pharmaceuticals US Inc.'s most recent federal contract award is Illuccix (36C25727N0009), from Veterans Integrated Service Network 17 (VHA), on October 26, 2026.
On GovTribe
See Telix Pharmaceuticals US Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors